Literature DB >> 15792674

Optimisation of the prothrombin complex concentrate dose for warfarin reversal.

M Makris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15792674     DOI： 10.1016/j.thromres.2004.10.005

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  7 in total

1.  Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding.

Authors:  Prashanth Panduranga; Mohammed Al-Mukhaini; Muhanna Al-Muslahi; Mohammed A Haque; Abdullah Shehab
Journal:  World J Cardiol       Date:  2012-03-26

Review 2.  Prothrombin complex concentrates: an update.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

3.  Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy.

Authors:  Cezary Wójcik; Michelle L Schymik; Eric G Cure
Journal:  Int J Emerg Med       Date:  2009-11-26

4.  Prothrombin complex concentrate (Beriplex P/N).

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

5.  Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals.

Authors:  Glenn Magee; Art Zbrozek
Journal:  Clinicoecon Outcomes Res       Date:  2013-06-26

6.  Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.

Authors:  Yun Wong
Journal:  Clin Med Insights Case Rep       Date:  2011-01-12

7.  Reversal of warfarin-induced hemorrhage in the emergency department.

Authors:  Meena Zareh; Andrew Davis; Sean Henderson
Journal:  West J Emerg Med       Date:  2011-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.